Concertai company information, Employees & Contact Information

ConcertAI Appoints Dr. Shaalan Beg as Chief Medical Officer, Oncology citybiz

ConcertAI Appoints Michael Myshrall as Chief Financial Officer Business Wire

RadNet’s Wholly-Owned Subsidiary, DeepHealth, and GlobeNewswire

Predictable Cost of Care Model for Treatment Decisions: Working Group Consensus Statements for Metastatic Non-Small Cell Lung Cancer HMP Global Learning Network

ConcertAI Provides Intelligent Automation of ASCO Guidelines into its Generative and Agentic AI Precision Suite™ and CancerLinQ SmartLinQ™ Solutions Business Wire

ConcertAI Appoints Eron Kelly as CEO citybiz

Caris Life Sciences and ConcertAI Expand Partnership to Create First-in-Class, Prospectively Matched Clinico-Genomic Research Platform PR Newswire

Life Sciences and Healthcare Leader ConcertAI Raises $150 Million Series C from Sixth Street at $1.9 Billion Valuation Sixth Street

Inside NVIDIA and ConcertAI's partnership to build AI agents for oncology trials drugdiscoverytrends.com

ConcertAI Introduces New Artificial Intelligence Solutions Powered by Real-World Data at ASCO 2024 Applied Clinical Trials

ConcertAI, Bayer join forces to advance precision oncology Mobi Health News

ConcertAI Launches New Generative and Agentic AI-Powered Precision Suite™ Accelerating Oncology Insights and Actions for Healthcare and Life Sciences Business Wire

ConcertAI Announces Strategic Agreement with Bayer to Accelerate Clinical Development in Precision Oncology Business Wire

Jennifer Rider Appointed ConcertAI Head of Real-World Evidence Services citybiz

ConcertAI presents CARAai Multi-LLM and Agentic AI for Clinical Development and Insights at NVIDIA GTC 2025 Business Wire

ConcertAI’s TeraRecon and 3DR Labs Announce Expanded Partnership to Transform the Delivery of AI-Enabled Image Post Processing Clinical Services for US Healthcare Providers Business Wire

Exigent Research, Leading National Community Research Network, Partners with AI Leader ConcertAI to Integrate CARAai™ Precision Trial Solutions Business Wire

ConcertAI and NeoGenomics Announce New AI Software-as-a-Service Solution for Hematology Clinical Research Business Wire

ConcertAI Appoints James Salitan as General Counsel Business Wire

After more than a decade, ASCO sells CancerLinQ to ConcertAI The Cancer Letter

Mike Rossi Joins ConcertAI as Chief Financial Officer, Bringing Deep Healthcare and Life Sciences Experience; Public Company Expertise PR Newswire

Guardant Health, ConcertAI Collaborate to Form First Data-As-A-Service That Integrates Clinical and Tumor Profiling Data to Accelerate Cancer Therapy Research and Development BioSpace

Identification of predictive subphenotypes for clinical outcomes using real world data and machine learning Nature

ASCO: ConcertAI announces Nvidia partnership, launches new AI tools Fierce Biotech

ConcertAI Names Claudio D’Ambrosio, PhD, as Chief Revenue Officer citybiz

Real-world evidence provides clinical insights into tissue-agnostic therapeutic approvals Nature

ConcertAI taps new CFO AuntMinnie

ConcertAI names new CEO AuntMinnie

ConcertAI Names Ronan Brown as Chief Operations Officer citybiz

ConcertAI expands multimodal data, RWD management AuntMinnie

Behavior of test specificity under an imperfect gold standard: findings from a simulation study and analysis of real-world oncology data BMC Medical Research Methodology

TeraRecon’s New Intuition Product Line Delivers AI Productivity and Industry-leading Cardiac MR Workflows, All Delivered Through a Robust Software-as-a-Service (SaaS) Platform Yahoo Finance

How ConcertAI aims to elevates CancerLinQ drugdiscoverytrends.com

Overall Survival in EGFR-Mutant Advanced NSCLC Treated With First-Line Osimertinib: A Cohort Study Integrating Clinical and Biomarker Data in the United States ScienceDirect.com

ConcertAI debuts latest clinical trial software upgrade to improve studies Fierce Biotech

JPM23: Caris teams up with ConcertAI on cancer trial data platforms Fierce Biotech

Labcorp taps ConcertAI for next-gen approach to clinical trials Fierce Biotech

ConcertAI hits $1.9B valuation with $150M series C for real-world data cancer research tools Fierce Healthcare

ConcertAI and Janssen deepen data-science collaboration drugdiscoverytrends.com

ConcertAI scores $150M, valuation skyrockets to nearly $2B Mobi Health News

Healthcare-focused AI and data startup ConcertAI bags $150M in Series C funding SiliconANGLE

AI oncology startup ConcertAI raises $150M in Series C funding drugdiscoverytrends.com

ConcertAI, a Startup Focused on Cancer Research, Raises $150 Million The Wall Street Journal

ConcertAI integrates with imaging technology specialist TeraRecon drugdiscoverytrends.com

AI-Based Clinical Trial Screening Is More Than 3X Faster Than Traditional Methods AiThority

Labcorp and ConcertAI Optimize Precision Oncology Research With Real-World Data and Artificial Intelligence FinancialContent

Racial disparities in Covid-19 are bad. They’re even worse in cancer statnews.com

ConcertAI hires Jitendra Gupta as first managing director of India Business Standard